Keyphrases
H3.3
100%
Kaposi Sarcoma
50%
Histone Variants
50%
Oral Cavity
25%
Histone Chaperone
25%
Daxx
25%
Latency
25%
Episome
18%
Chaperone
18%
Viral Gene
12%
AIDS Patients
12%
Castleman
12%
Histone Post-translational Modifications
12%
CENP-A
12%
Combined Antiretroviral Therapy (cART)
12%
College of Dentistry
12%
Potential Hosts
12%
Epigenetic Status
12%
Head-and-neck
12%
Sarcoma
12%
Gingival Epithelial Cells
12%
Latency Control
12%
Virus Transmission
12%
Epigenetic Marks
12%
Multicentric
12%
Oral Transmission
12%
Lytic Infection
12%
Saliva
12%
Snapping
12%
Oral Cancer
12%
Gene Products
12%
Herpesvirus
6%
Latent Infection
6%
Endothelial Cells
6%
Epigenetics
6%
Epigenetic Modification
6%
Epithelial Cell Line
6%
Lymphoproliferative Disorders
6%
Latently Infected
6%
Etiological Agents
6%
Infected Cells
6%
Primary Effusion Lymphoma
6%
Chromatin Remodelers
6%
Novel Therapeutic Targets
6%
Viral Gene Expression
6%
Tumor Samples
6%
Latency-associated nuclear Antigen
6%
Type-specific
6%
Deregulation
6%
Tumor Cells
6%
Epigenome
6%
Associated Genes
6%
Histone
6%
Cohen
6%
Viral Episome
6%
Lymphoid Cells
6%
AIDS/HIV
6%
Virus-host Interactions
6%
Epithelial Cells
6%
Primary Infection
6%
Multiple Persons
6%
Medicine and Dentistry
Episome
50%
Histone
50%
Kaposi Sarcoma
50%
Chaperone
37%
Oral Cavity
25%
Infection
25%
HIRA
25%
Neck
12%
Oral Cancer
12%
Epigenetic Modification
12%
Virus Transmission
12%
Sarcoma
12%
Epithelial Cell Line
12%
Lymphoid Cell
12%
Gene Product
12%
Epithelial Cell
12%
Protein Processing
12%
Centromere Protein A
12%
Epigenomics
6%
Cas9
6%
Antiretroviral Therapy
6%
Dentistry
6%
Endothelial Cell
6%
Human Immunodeficiency Virus
6%
Virus Gene
6%
Lymphoproliferative Disease
6%
Recurrent Disease
6%
Neoplasm
6%
Primary Infection
6%
Herpesviridae
6%
Latency Associated Nuclear Antigen
6%
Gene Expression
6%
Primary Effusion Lymphoma
6%
Tumor Cell
6%